Lisa A. Mingle
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Lisa A. Mingle has a total of 46 co-authors. Here are the top co-authors by number of shared publications:
- Kimberlee Arruda Musser
Wadsworth Center, New York State Department of Health, Albany, NY, USA
5 shared publications - Samantha E. Wirth
New York State Department of Health, Wadsworth Center
4 shared publications - Cheryl P. Andam
Department of Biological Sciences, University at Albany, State University of New York , NY 12222
3 shared publications - Odion Osebhahiemen Ikhimiukor
Wadsworth Center, New York State Department of Health, Albany, NY, USA
3 shared publications - Ana Beatriz Garcez Buiatte
Department of Biological Sciences, University at Albany, State University of New York, Albany, USA
2 shared publications - Ashley E. Cukrovany
Wadsworth Center, New York State Department of Health, Albany, New York, USA
2 shared publications
Latest Publications
- Open Access
- 2 September 2026
- Published by Microbiology Society in Microbial Genomics
- Vol. 12 (9) , 001816
Presence of globally prominent multidrug-resistant genotypes of Salmonella enterica serovar Typhi in New York State, 2016–2023
The human-restricted enteric pathogen Salmonella enterica serovar Typhi ( S . Typhi) is the causative agent of the life-threatening typhoid fever. Although S . Typhi incidence is relatively low in the USA, routine surveillance of S . Typhi is critical to track the emergence and spread of high-risk lineages in non-endemic areas. In this study, we analysed 151 genomes of S . Typhi isolates from patients who were clinically confirmed with typhoid fever across New York State between 2016 and 2023. We used the GenoTyphi classification scheme and identified established multidrug-resistant and extensively drug-resistant lineages. We detected the presence of the globally widespread genotype 4.3.1 (haplotype 58) and its derivative 4.3.1.1.P1, which recently emerged in Pakistan, as well as the Bangladesh-restricted lineages 3.3.2.Bd1 and 3.3.2.Bd2 in our dataset. Ten mutations and 14 acquired genes associated with antimicrobial resistance (AMR) were present across the entire population, with 86.8% of the genomes possessing at least one of these AMR determinants. The gyrA S83F mutation conferring quinolone and triclosan resistance was the most frequently detected (94 genomes). Combinations of dfrA7+catA1 (resistance to trimethoprim and chloramphenicol, respectively) and sul2+aph(3″)-Ib+aph(6)-Id (resistance to sulphonamide and aminoglycosides, respectively) co-occurred frequently and were associated with IncQ and IncY plasmid replicons. Phylogenetic contextualization against a global dataset of 1,643 genomes from 20 countries across five continents, including other parts of the USA, from the same time period showed geographic intermingling, suggesting the spread of high-risk genotypes of international origins to New York State. Altogether, these findings reveal the presence of globally dominant resistant genotypes that are likely facilitated by human travel in New York State, where typhoid fever is not endemic. Long-term genomic surveillance is critical to AMR profiling, identifying genotypic shifts in regional S . Typhi populations, monitoring transmission routes and guiding effective public health interventions.
- 2 September 2026
- Published by Microbiology Society in Microbial Genomics
- Vol. 12 (9) , 001816
Open AccessPresence of globally prominent multidrug-resistant genotypes of Salmonella enterica serovar Typhi in New York State, 2016–2023
The human-restricted enteric pathogen Salmonella enterica serovar Typhi ( S . Typhi) is the causative agent of the life-threatening typhoid fever. Although S . Typhi incidence is relatively low in the USA, routine surveillance of S . Typhi is critical to track the emergence and spread of high-risk lineages in non-endemic areas. In this study, we analysed 151 genomes of S . Typhi isolates from patients who were clinically confirmed with typhoid fever across New York State between 2016 and 2023. We used the GenoTyphi classification scheme and identified established multidrug-resistant and extensively drug-resistant lineages. We detected the presence of the globally widespread genotype 4.3.1 (haplotype 58) and its derivative 4.3.1.1.P1, which recently emerged in Pakistan, as well as the Bangladesh-restricted lineages 3.3.2.Bd1 and 3.3.2.Bd2 in our dataset. Ten mutations and 14 acquired genes associated with antimicrobial resistance (AMR) were present across the entire population, with 86.8% of the genomes possessing at least one of these AMR determinants. The gyrA S83F mutation conferring quinolone and triclosan resistance was the most frequently detected (94 genomes). Combinations of dfrA7+catA1 (resistance to trimethoprim and chloramphenicol, respectively) and sul2+aph(3″)-Ib+aph(6)-Id (resistance to sulphonamide and aminoglycosides, respectively) co-occurred frequently and were associated with IncQ and IncY plasmid replicons. Phylogenetic contextualization against a global dataset of 1,643 genomes from 20 countries across five continents, including other parts of the USA, from the same time period showed geographic intermingling, suggesting the spread of high-risk genotypes of international origins to New York State. Altogether, these findings reveal the presence of globally dominant resistant genotypes that are likely facilitated by human travel in New York State, where typhoid fever is not endemic. Long-term genomic surveillance is critical to AMR profiling, identifying genotypic shifts in regional S . Typhi populations, monitoring transmission routes and guiding effective public health interventions.
- Open Access
- 6 January 2026
- Published by American Society for Microbiology in Microbiology Spectrum
- Vol. 14 (1) , e0095625
Genomic epidemiology reveals statewide dispersal of clinical Shiga toxin-producing Escherichia coli and their antimicrobial resistome
Shiga toxin-producing Escherichia coli (STEC) is a zoonotic pathogen that can be transmitted to humans through contaminated food or contact with infected animals. Here, we aim to characterize the population diversity and genome characteristics of the clinical STEC population in New York State collected over a span of six years. A total of 1,655 clinical isolates were analyzed using whole-genome sequencing, phylogenetic reconstruction, in silico identification of acquired antimicrobial resistance genes and plasmid types, and delineation of genetic clusters. The STEC population consists of 178 serotypes based on unique combinations of the O and H antigens. Four serotypes were most frequently detected: O103:H2 ( n = 295 genomes), O157:H7 ( n = 207), O26:H11 ( n = 137), and O111:H8 ( n = 126). The accessory genome content of O157:H7 was more divergent from those of other three serotypes. A total of 93 genetic determinants associated with resistance to 13 classes of antimicrobial agents were identified. Across the whole data set, we detected 10 subtypes of the Shiga toxin gene stx . The gene encoding intimin ( eae ) was present in 70.39% of the genomes. Of the 56 plasmid replicon types detected, the most abundant was IncFIB(AP001918). Using a cutoff of 10 SNPs in the core gene alignment, we identified 28 genetic clusters implicating at least ten serotypes. O157:H7 genomes were identified in eight clusters. These genetically linked cases, spanning anywhere between 1 day and 63 months and traversing multiple counties across the state, suggest either cryptic outbreaks or long-term local persistence. IMPORTANCE: Shiga toxin-producing Escherichia coli (STEC) infections are a major public health burden. We show that while serotypes O103:H2 and O157:H7 remain the major causes of STEC infections in New York State, the rising incidence of less common serotypes is a cause of concern, especially given the large pool of AMR, virulence genes, and plasmids they carry. Genomic surveillance of STEC is critical in informing public health efforts to reduce the burden of multidrug-resistant STEC, minimize onward transmission, and prevent more severe disease outcomes.
- 6 January 2026
- Published by American Society for Microbiology in Microbiology Spectrum
- Vol. 14 (1) , e0095625
Open AccessGenomic epidemiology reveals statewide dispersal of clinical Shiga toxin-producing Escherichia coli and their antimicrobial resistome
Shiga toxin-producing Escherichia coli (STEC) is a zoonotic pathogen that can be transmitted to humans through contaminated food or contact with infected animals. Here, we aim to characterize the population diversity and genome characteristics of the clinical STEC population in New York State collected over a span of six years. A total of 1,655 clinical isolates were analyzed using whole-genome sequencing, phylogenetic reconstruction, in silico identification of acquired antimicrobial resistance genes and plasmid types, and delineation of genetic clusters. The STEC population consists of 178 serotypes based on unique combinations of the O and H antigens. Four serotypes were most frequently detected: O103:H2 ( n = 295 genomes), O157:H7 ( n = 207), O26:H11 ( n = 137), and O111:H8 ( n = 126). The accessory genome content of O157:H7 was more divergent from those of other three serotypes. A total of 93 genetic determinants associated with resistance to 13 classes of antimicrobial agents were identified. Across the whole data set, we detected 10 subtypes of the Shiga toxin gene stx . The gene encoding intimin ( eae ) was present in 70.39% of the genomes. Of the 56 plasmid replicon types detected, the most abundant was IncFIB(AP001918). Using a cutoff of 10 SNPs in the core gene alignment, we identified 28 genetic clusters implicating at least ten serotypes. O157:H7 genomes were identified in eight clusters. These genetically linked cases, spanning anywhere between 1 day and 63 months and traversing multiple counties across the state, suggest either cryptic outbreaks or long-term local persistence. IMPORTANCE: Shiga toxin-producing Escherichia coli (STEC) infections are a major public health burden. We show that while serotypes O103:H2 and O157:H7 remain the major causes of STEC infections in New York State, the rising incidence of less common serotypes is a cause of concern, especially given the large pool of AMR, virulence genes, and plasmids they carry. Genomic surveillance of STEC is critical in informing public health efforts to reduce the burden of multidrug-resistant STEC, minimize onward transmission, and prevent more severe disease outcomes.
- Open Access
- 2 April 2025
- Published by SAGE Publications in Foodborne Pathogens and Disease
- Vol. 22 (4) , 273-280
Shiga Toxin–Producing Escherichia coli Testing in New York 2011–2022 Reveals Increase in Non-O157 Identifications
Shiga toxin–producing Escherichia coli (STEC) are an important cause of bacterial enteric infection. STEC strains cause serious human gastrointestinal disease, which may result in life-threatening complications such as hemolytic uremic syndrome. They have the potential to impact public health due to diagnostic challenges of identifying non-O157 strains in the clinical laboratory. The Wadsworth Center (WC), the public health laboratory of the New York State Department of Health, has isolated and identified non-O157 STEC for decades. A shift from initially available enzyme immunoassay testing to culture-independent diagnostic tests (CIDTs) has increased the uptake of testing at clinical microbiology laboratories. This testing change has resulted in an increased number of specimen submissions to WC. During a 12-year period between 2011 and 2022, WC received 5037 broths and/or stool specimens for STEC confirmation from clinical microbiology laboratories. Of these, 3992 were positive for Shiga toxin genes ( stx1 and/or stx2 ) by real-time PCR. Furthermore, culture methods were utilized to isolate, identify, and characterize 2925 STEC from these primary specimens. Notably, WC observed a >200% increase in the number of STEC specimens received in 2021–2022 compared with 2011–2012 and an 18% increase in the number of non-O157 STEC identified using the same methodologies. During the past decade, the WC testing algorithm has been updated to manage the increase in specimens received, while also navigating the novel COVID-19 pandemic, which took priority over other testing for a period of time. This report summarizes updated methods for confirmation, surveillance, and outbreak detection of STEC and describes findings that may be related to our algorithm updates and the increased use of CIDTs, which is starting to elucidate the true incidence of non-O157 STEC.
- 2 April 2025
- Published by SAGE Publications in Foodborne Pathogens and Disease
- Vol. 22 (4) , 273-280
Open AccessShiga Toxin–Producing Escherichia coli Testing in New York 2011–2022 Reveals Increase in Non-O157 Identifications
Shiga toxin–producing Escherichia coli (STEC) are an important cause of bacterial enteric infection. STEC strains cause serious human gastrointestinal disease, which may result in life-threatening complications such as hemolytic uremic syndrome. They have the potential to impact public health due to diagnostic challenges of identifying non-O157 strains in the clinical laboratory. The Wadsworth Center (WC), the public health laboratory of the New York State Department of Health, has isolated and identified non-O157 STEC for decades. A shift from initially available enzyme immunoassay testing to culture-independent diagnostic tests (CIDTs) has increased the uptake of testing at clinical microbiology laboratories. This testing change has resulted in an increased number of specimen submissions to WC. During a 12-year period between 2011 and 2022, WC received 5037 broths and/or stool specimens for STEC confirmation from clinical microbiology laboratories. Of these, 3992 were positive for Shiga toxin genes ( stx1 and/or stx2 ) by real-time PCR. Furthermore, culture methods were utilized to isolate, identify, and characterize 2925 STEC from these primary specimens. Notably, WC observed a >200% increase in the number of STEC specimens received in 2021–2022 compared with 2011–2012 and an 18% increase in the number of non-O157 STEC identified using the same methodologies. During the past decade, the WC testing algorithm has been updated to manage the increase in specimens received, while also navigating the novel COVID-19 pandemic, which took priority over other testing for a period of time. This report summarizes updated methods for confirmation, surveillance, and outbreak detection of STEC and describes findings that may be related to our algorithm updates and the increased use of CIDTs, which is starting to elucidate the true incidence of non-O157 STEC.
- Open Access
- 4 September 2024
- Published by Springer Nature in Genome Medicine
- Vol. 16 (1) , 1-14
Long-term persistence of diverse clones shapes the transmission landscape of invasive Listeria monocytogenes
The foodborne bacterium Listeria monocytogenes (Lm) causes a range of diseases, from mild gastroenteritis to invasive infections that have high fatality rate in vulnerable individuals. Understanding the population genomic structure of invasive Lm is critical to informing public health interventions and infection control policies that will be most effective especially in local and regional communities. We sequenced the whole draft genomes of 936 Lm isolates from human clinical samples obtained in a two-decade active surveillance program across 58 counties in New York State, USA. Samples came mostly from blood and cerebrospinal fluid. We characterized the phylogenetic relationships, population structure, antimicrobial resistance genes, virulence genes, and mobile genetic elements. The population is genetically heterogenous, consisting of lineages I–IV, 89 clonal complexes, 200 sequence types, and six known serogroups. In addition to intrinsic antimicrobial resistance genes (fosX, lin, norB, and sul), other resistance genes tetM, tetS, ermG, msrD, and mefA were sparsely distributed in the population. Within each lineage, we identified clusters of isolates with ≤ 20 single nucleotide polymorphisms in the core genome alignment. These clusters may represent isolates that share a most recent common ancestor, e.g., they are derived from the same contamination source or demonstrate evidence of transmission or outbreak. We identified 38 epidemiologically linked clusters of isolates, confirming eight previously reported disease outbreaks and the discovery of cryptic outbreaks and undetected chains of transmission, even in the rarely reported Lm lineage III (ST3171). The presence of animal-associated lineages III and IV may suggest a possible spillover of animal-restricted strains to humans. Many transmissible clones persisted over several years and traversed distant sites across the state. Our findings revealed the bacterial determinants of invasive listeriosis, driven mainly by the diversity of locally circulating lineages, intrinsic and mobile antimicrobial resistance and virulence genes, and persistence across geographical and temporal scales. Our findings will inform public health efforts to reduce the burden of invasive listeriosis, including the design of food safety measures, source traceback, and outbreak detection.
- 4 September 2024
- Published by Springer Nature in Genome Medicine
- Vol. 16 (1) , 1-14
Open AccessLong-term persistence of diverse clones shapes the transmission landscape of invasive Listeria monocytogenes
The foodborne bacterium Listeria monocytogenes (Lm) causes a range of diseases, from mild gastroenteritis to invasive infections that have high fatality rate in vulnerable individuals. Understanding the population genomic structure of invasive Lm is critical to informing public health interventions and infection control policies that will be most effective especially in local and regional communities. We sequenced the whole draft genomes of 936 Lm isolates from human clinical samples obtained in a two-decade active surveillance program across 58 counties in New York State, USA. Samples came mostly from blood and cerebrospinal fluid. We characterized the phylogenetic relationships, population structure, antimicrobial resistance genes, virulence genes, and mobile genetic elements. The population is genetically heterogenous, consisting of lineages I–IV, 89 clonal complexes, 200 sequence types, and six known serogroups. In addition to intrinsic antimicrobial resistance genes (fosX, lin, norB, and sul), other resistance genes tetM, tetS, ermG, msrD, and mefA were sparsely distributed in the population. Within each lineage, we identified clusters of isolates with ≤ 20 single nucleotide polymorphisms in the core genome alignment. These clusters may represent isolates that share a most recent common ancestor, e.g., they are derived from the same contamination source or demonstrate evidence of transmission or outbreak. We identified 38 epidemiologically linked clusters of isolates, confirming eight previously reported disease outbreaks and the discovery of cryptic outbreaks and undetected chains of transmission, even in the rarely reported Lm lineage III (ST3171). The presence of animal-associated lineages III and IV may suggest a possible spillover of animal-restricted strains to humans. Many transmissible clones persisted over several years and traversed distant sites across the state. Our findings revealed the bacterial determinants of invasive listeriosis, driven mainly by the diversity of locally circulating lineages, intrinsic and mobile antimicrobial resistance and virulence genes, and persistence across geographical and temporal scales. Our findings will inform public health efforts to reduce the burden of invasive listeriosis, including the design of food safety measures, source traceback, and outbreak detection.
- Open Access
- 15 June 2023
- Published by SAGE Publications in Foodborne Pathogens and Disease
- Vol. 20 (6) , 230-236
Challenges Associated with Investigating Salmonella Enteritidis with Low Genomic Diversity in New York State: The Impact of Adjusting Analytical Methods and Correlation with Epidemiological Data
Defining investigation-worthy genomic clusters among strains of Salmonella Enteritidis is challenging because of their highly clonal nature. We investigated a cluster identified by core genome multilocus sequence typing (cgMLST) consisting of 265 isolates with isolation dates spanning two and a half years. This cluster experienced chaining, growing to a range of 14 alleles. The volume of isolates and broad allele range of this cluster made it difficult to ascertain whether it represented a common-source outbreak. We explored laboratory-based methods to subdivide and refine this cluster. These methods included using cgMLST with a narrower allele range, whole genome multilocus sequence typing (wgMLST) and high-quality single-nucleotide polymorphism (hqSNP) analysis. At each analysis level, epidemiologists retroactively reviewed exposures, geography, and temporality for potential commonalities. Lowering the threshold to 0 alleles using cgMLST proved an effective method to refine this analysis, resulting in this large cluster being subdivided into 34 smaller clusters. Additional analysis by wgMLST and hqSNP provided enhanced cluster resolution, with the majority of clusters being further refined. These analysis methods combined with more stringent allele thresholds and layering of epidemiologic data proved useful in helping to subdivide this large cluster into actionable subclusters.
- 15 June 2023
- Published by SAGE Publications in Foodborne Pathogens and Disease
- Vol. 20 (6) , 230-236
Open AccessChallenges Associated with Investigating Salmonella Enteritidis with Low Genomic Diversity in New York State: The Impact of Adjusting Analytical Methods and Correlation with Epidemiological Data
Defining investigation-worthy genomic clusters among strains of Salmonella Enteritidis is challenging because of their highly clonal nature. We investigated a cluster identified by core genome multilocus sequence typing (cgMLST) consisting of 265 isolates with isolation dates spanning two and a half years. This cluster experienced chaining, growing to a range of 14 alleles. The volume of isolates and broad allele range of this cluster made it difficult to ascertain whether it represented a common-source outbreak. We explored laboratory-based methods to subdivide and refine this cluster. These methods included using cgMLST with a narrower allele range, whole genome multilocus sequence typing (wgMLST) and high-quality single-nucleotide polymorphism (hqSNP) analysis. At each analysis level, epidemiologists retroactively reviewed exposures, geography, and temporality for potential commonalities. Lowering the threshold to 0 alleles using cgMLST proved an effective method to refine this analysis, resulting in this large cluster being subdivided into 34 smaller clusters. Additional analysis by wgMLST and hqSNP provided enhanced cluster resolution, with the majority of clusters being further refined. These analysis methods combined with more stringent allele thresholds and layering of epidemiologic data proved useful in helping to subdivide this large cluster into actionable subclusters.
- Open Access
- 28 February 2022
- Published by Elsevier in International Journal of Infectious Diseases
- Vol. 116, S78
Updated Algorithm for the Enhanced Detection, Isolation, and Identification of Shiga Toxin-Producing Escherichia coli, NYSDOH, 2011-2020
- 28 February 2022
- Published by Elsevier in International Journal of Infectious Diseases
- Vol. 116, S78
Open AccessUpdated Algorithm for the Enhanced Detection, Isolation, and Identification of Shiga Toxin-Producing Escherichia coli, NYSDOH, 2011-2020
- 24 May 2019
- Published by Oxford University Press (OUP) in Letters in Applied Microbiology
- Vol. 69 (2) , 116-120
Detection ofSalmonellaspp. in retail meat products: a comparison between a discontinued commercial kit and a laboratory‐developed screening method
The National Antimicrobial Resistance Monitoring System for Enteric Bacteria (NARMS) Retail Food Surveillance (RFS) Program screens retail meat samples for the presence of Salmonella spp. to track antimicrobial resistance in food. In this study, a laboratory developed real‐time PCR assay that detects Salmonella spp. was evaluated as a screening method to replace the discountinued 3M™ TECRA™ kit. The 3M™ TECRA™ kit was a commercially available, visual immunoassay used to screen food samples for the presence of Salmonella spp. This kit was discontinued in September 2016 by the manufacturer and an alternative screening method was needed to replace the discontinued TECRA™ kit. Salmonella spp. is detected by the real‐time PCR assay earlier in the screening process than by the TECRA™ kit. Salmonella spp. can also be reliably isolated from the enrichment broth earlier in the protocol. Additionally, cost analysis shows that the real‐time PCR assay saves $2.50 per sample. NYSDOH currently uses this real‐time PCR assay as a screening method for the presence of Salmonella spp. in retail meat samples. The assay allows for continued monitoring of antimicrobial resistance in Salmonella spp., while providing a cost savings and a decrease in turnaround time.
- 24 May 2019
- Published by Oxford University Press (OUP) in Letters in Applied Microbiology
- Vol. 69 (2) , 116-120
Detection ofSalmonellaspp. in retail meat products: a comparison between a discontinued commercial kit and a laboratory‐developed screening method
The National Antimicrobial Resistance Monitoring System for Enteric Bacteria (NARMS) Retail Food Surveillance (RFS) Program screens retail meat samples for the presence of Salmonella spp. to track antimicrobial resistance in food. In this study, a laboratory developed real‐time PCR assay that detects Salmonella spp. was evaluated as a screening method to replace the discountinued 3M™ TECRA™ kit. The 3M™ TECRA™ kit was a commercially available, visual immunoassay used to screen food samples for the presence of Salmonella spp. This kit was discontinued in September 2016 by the manufacturer and an alternative screening method was needed to replace the discontinued TECRA™ kit. Salmonella spp. is detected by the real‐time PCR assay earlier in the screening process than by the TECRA™ kit. Salmonella spp. can also be reliably isolated from the enrichment broth earlier in the protocol. Additionally, cost analysis shows that the real‐time PCR assay saves $2.50 per sample. NYSDOH currently uses this real‐time PCR assay as a screening method for the presence of Salmonella spp. in retail meat samples. The assay allows for continued monitoring of antimicrobial resistance in Salmonella spp., while providing a cost savings and a decrease in turnaround time.
- 1 November 2012
- Published by SAGE Publications in Foodborne Pathogens and Disease
- Vol. 9 (11) , 1028-1036
Enhanced Identification and Characterization of Non-O157 Shiga Toxin–Producing Escherichia coli : A Six-Year Study
Non-O157 Shiga toxin–producing Escherichia coli (STEC) are emerging pathogens with the potential to cause serious illness and impact public health due to diagnostic challenges. Between 2005 and 2010, the Wadsworth Center (WC), the public health laboratory of the New York State (NYS) Department of Health, requested that Shiga toxin enzyme immunoassay (EIA)–positive stool enrichment broths and/or stool specimens be submitted by clinical and commercial reference laboratories testing NYS patient specimens. A total of 798 EIA-positive specimens were received for confirmation and serotyping, and additionally a subset of STEC was assessed for the presence of six virulence genes (stx1, stx2, eaeA, hlyA, nleA, and nleB) by real-time polymerase chain reaction. We confirmed 591 specimens as STEC, 164 (28%) as O157 STEC, and 427 (72%) as non-O157 STEC. Of the non-O157 STEC serogroups identified, over 70% were O103, O26, O111, O45, O121, or O145. During this time period, WC identified and characterized a total of 1282 STEC received as E. coli isolates, stool specimens, or EIA broths. Overall, the STEC testing identified 59% as O157 STEC and 41% as non-O157 STEC; however, out of 600 isolates submitted to the WC as E. coli cultures, 543 (90%) were identified as O157 STEC. This report summarizes a 6-year study utilizing enhanced STEC testing that resulted in increased identification and characterization of non-O157 STEC in NYS. Continued utilization of enhanced STEC testing may lead to effective and timely outbreak response and improve monitoring of trends in STEC disease epidemiology.
- 1 November 2012
- Published by SAGE Publications in Foodborne Pathogens and Disease
- Vol. 9 (11) , 1028-1036
Enhanced Identification and Characterization of Non-O157 Shiga Toxin–Producing Escherichia coli : A Six-Year Study
Non-O157 Shiga toxin–producing Escherichia coli (STEC) are emerging pathogens with the potential to cause serious illness and impact public health due to diagnostic challenges. Between 2005 and 2010, the Wadsworth Center (WC), the public health laboratory of the New York State (NYS) Department of Health, requested that Shiga toxin enzyme immunoassay (EIA)–positive stool enrichment broths and/or stool specimens be submitted by clinical and commercial reference laboratories testing NYS patient specimens. A total of 798 EIA-positive specimens were received for confirmation and serotyping, and additionally a subset of STEC was assessed for the presence of six virulence genes (stx1, stx2, eaeA, hlyA, nleA, and nleB) by real-time polymerase chain reaction. We confirmed 591 specimens as STEC, 164 (28%) as O157 STEC, and 427 (72%) as non-O157 STEC. Of the non-O157 STEC serogroups identified, over 70% were O103, O26, O111, O45, O121, or O145. During this time period, WC identified and characterized a total of 1282 STEC received as E. coli isolates, stool specimens, or EIA broths. Overall, the STEC testing identified 59% as O157 STEC and 41% as non-O157 STEC; however, out of 600 isolates submitted to the WC as E. coli cultures, 543 (90%) were identified as O157 STEC. This report summarizes a 6-year study utilizing enhanced STEC testing that resulted in increased identification and characterization of non-O157 STEC in NYS. Continued utilization of enhanced STEC testing may lead to effective and timely outbreak response and improve monitoring of trends in STEC disease epidemiology.